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Background
Stat transcription factors are highly conserved key regula-
tors of cellular processes such as proliferation, differentia-
tion, growth and apoptosis. Stats have been frequently
found to be deregulated in cancer. One example is the
constitutive activation of Stat5 in chronic myelogenous
leukaemia (CML). The disease is caused by a chromoso-
mal translocation resulting in the expression of the Bcr/
Abl fusion kinase. The transcription factor Stat5 is
required for Bcr/Abl-induced leukaemic initiation and dis-
ease progression. Furthermore, serine phosphorylation of
a constitutive active form of Stat5 is crucial for haemato-
poietic transformation. These findings put Stat5 into the
spotlight of new therapeutic tactics. Here, we screen for
kinases phosphorylating Stat5 by employing a cell viabi-
lity-based screening approach.
Methods
Stable leukemic cell lines expressing variants of the bcr/abl
oncogene and different levels of the Stat5 protein were
screened for the induction of apoptosis with purchased
kinase inhibitor libraries. Additionally, cells over-expres-
sing phospho-mimetic mutants were included in the
screening and served as controls for specificity.
Results
We showed that serine phosphorylation of Stat5 is
required to prevent apoptosis in Bcr/Abl-dependent cell
lines. Therefore, we used a cell viability-based screening
assay showing that 42 of 300 kinase inhibitors induced
apoptosis in Bcr/Abl-dependent cell lines. Predomi-
nately, those hit compounds were inhibiting members of
the CMGC kinase family, which are primarily proline-
directed serine/threonine kinases. Furthermore, cell lines
with endogenous levels of Stat5 and over-expressing
wild-type Stat5 were compared in an additional round
of screening. The resulting 6 hit compounds, which
inhibit CDKs, GSK3, PKC and p38 MAP kinase, are cur-
rently being validated by Western blot analysis with
phospho-Stat5 specific antisera.
Conclusions
These findings point towards the importance of CMGC
kinase family members for survival of Bcr/Abl-dependent
leukaemic cell lines.
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